欧洲空间局的ENVISAT ASAR level 2算法是从合成孔径雷达(SAR)单视复图像反演涌浪方向谱的算法。该算法假设双峰海浪谱的SAR图像交叉谱是涌浪的图像交叉谱和风浪的图像交叉谱之和。实际上双峰海浪谱的SAR图像交叉谱中还有一个混合项,正...欧洲空间局的ENVISAT ASAR level 2算法是从合成孔径雷达(SAR)单视复图像反演涌浪方向谱的算法。该算法假设双峰海浪谱的SAR图像交叉谱是涌浪的图像交叉谱和风浪的图像交叉谱之和。实际上双峰海浪谱的SAR图像交叉谱中还有一个混合项,正是该混合项导致ENVI-SAT ASAR level 2算法有固有误差。利用遥感仿真的方法分析了不同海况条件下该算法的这一固有误差,结果表明,只有在有效波高较小、或风浪的成分较少、或双峰海浪的传播方向较靠近SAR距离向、或波长较长时固有误差才较小,ENVISAT ASAR level 2算法对海浪谱的反演才较为适用。展开更多
Concern about the biological hazards involved in microbiological research, especially research involving laboratory animals, has increased in recent years. Working in an animal biosafety level 2 facility （ABSL-2）, c...Concern about the biological hazards involved in microbiological research, especially research involving laboratory animals, has increased in recent years. Working in an animal biosafety level 2 facility （ABSL-2）, commonly used for research on infectious diseases, poses various biological hazards. Here, the regulations and standards related to laboratory biosafety in China are introduced, the potential biological hazards present in ABSL-2 facilities are analyzed, and a series of strategies to control the hazards are presented.展开更多
Background: The COVID-19 pandemic continues to be a major worldwide health problem. The present study aims to contribute to surveillance of the immune and clinical response of vaccines to SARS-CoV-2. Methods: Observat...Background: The COVID-19 pandemic continues to be a major worldwide health problem. The present study aims to contribute to surveillance of the immune and clinical response of vaccines to SARS-CoV-2. Methods: Observational medication study on acquired immunity and effectiveness of vaccines. Population: 620 workers in the health service of Almansa (Spain). Representative sample of 150 individuals. Sociodemographic, clinical, and epidemiological data and samples were recorded to determine anti-SARS-CoV-2 serum IgG levels 6 and 9 months after vaccination with Pfizer. Results: Mean age 46.45 years;76% women;85.1% working in a hospital. 19.3% had had COVID-19 in the year prior to vaccination. 96.7% were fully vaccinated with Pfizer/BioNTech. At 6 months, 100% seropositivity and mean IgG levels of 3017.2 AU/ml. Significant variations in IgG levels in individuals with prior COVID-19 infection and smokers. At 9 months, 99.3% remained seropositive;2.8% infected after vaccination. The repeated measures analysis showed a difference in means of 669.0 AU/ml (significant decrease in IgG levels of 28.9%). Conclusion: Antibody levels remained positive 6 and 9 months after vaccination, although IgG levels were found to decay.展开更多
文摘欧洲空间局的ENVISAT ASAR level 2算法是从合成孔径雷达(SAR)单视复图像反演涌浪方向谱的算法。该算法假设双峰海浪谱的SAR图像交叉谱是涌浪的图像交叉谱和风浪的图像交叉谱之和。实际上双峰海浪谱的SAR图像交叉谱中还有一个混合项,正是该混合项导致ENVI-SAT ASAR level 2算法有固有误差。利用遥感仿真的方法分析了不同海况条件下该算法的这一固有误差,结果表明,只有在有效波高较小、或风浪的成分较少、或双峰海浪的传播方向较靠近SAR距离向、或波长较长时固有误差才较小,ENVISAT ASAR level 2算法对海浪谱的反演才较为适用。
基金supported by the National Science and Technology Major Projects of Infectious Disease(2012ZX10004-404)
文摘Concern about the biological hazards involved in microbiological research, especially research involving laboratory animals, has increased in recent years. Working in an animal biosafety level 2 facility （ABSL-2）, commonly used for research on infectious diseases, poses various biological hazards. Here, the regulations and standards related to laboratory biosafety in China are introduced, the potential biological hazards present in ABSL-2 facilities are analyzed, and a series of strategies to control the hazards are presented.
文摘Background: The COVID-19 pandemic continues to be a major worldwide health problem. The present study aims to contribute to surveillance of the immune and clinical response of vaccines to SARS-CoV-2. Methods: Observational medication study on acquired immunity and effectiveness of vaccines. Population: 620 workers in the health service of Almansa (Spain). Representative sample of 150 individuals. Sociodemographic, clinical, and epidemiological data and samples were recorded to determine anti-SARS-CoV-2 serum IgG levels 6 and 9 months after vaccination with Pfizer. Results: Mean age 46.45 years;76% women;85.1% working in a hospital. 19.3% had had COVID-19 in the year prior to vaccination. 96.7% were fully vaccinated with Pfizer/BioNTech. At 6 months, 100% seropositivity and mean IgG levels of 3017.2 AU/ml. Significant variations in IgG levels in individuals with prior COVID-19 infection and smokers. At 9 months, 99.3% remained seropositive;2.8% infected after vaccination. The repeated measures analysis showed a difference in means of 669.0 AU/ml (significant decrease in IgG levels of 28.9%). Conclusion: Antibody levels remained positive 6 and 9 months after vaccination, although IgG levels were found to decay.
